Treating Hypertension During Pregnancy: Benefits Seem to Outweigh Risks.

[Argirios Argiriou]

January 28, 2015

Treating Hypertension During Pregnancy: Benefits Seem to Outweigh Risks

Eleanor Bimla Schwarz, MD, MS reviewing Magee LA et al. N Engl J Med 2015 Jan 29.

Fetal and neonatal outcomes were not adversely affected by a maternal diastolic target of 85 mm Hg.

Almost 10% of pregnancies are affected by hypertension, yet many clinicians remain reluctant to prescribe antihypertensives during pregnancy. To evaluate the effects of “less-tight” (diastolic target, 100 mm Hg) versus “tight” (diastolic target, 85 mm Hg) blood pressure (BP) control during pregnancy, researchers conducted an open-label multicenter trial in which 987 pregnant women were randomly assigned to either target. Participants had nonsevere, nonproteinuric preexisting hypertension or gestational hypertension (diastolic BP, 90–105 mm Hg without medication or 85–105 mm Hg with medication) and singleton pregnancies (gestation, 14 weeks 0 days to 33 weeks 6 days).

In both groups, labetalol was the most commonly used antihypertensive, (στην Ελλάδα η labetalol κυκλοφορεί από τον ΙΦΕΤ με το εμπορικό όνομα Trandate ) but more women required medication to reach the tighter goal. Rates of pregnancy loss, low birth weight, and need for neonatal intensive care were similar between groups. However, significantly fewer women treated with tighter control developed abnormally low platelet counts (1.6% vs. 4.3%) or elevated liver function tests (1.8% vs. 4.3%), with a trend toward less need for blood transfusion (1.6% vs. 3.2%). (υπονοεί ότι αυτές που παίρναν την labetalol είχαν μικρότερο κίνδυνο για HELLP)

COMMENT

Although we still need to identify optimal approaches to managing hypertension during pregnancy, this rigorous trial should reassure many clinicians that the benefits of treating maternal hypertension with labetalol during pregnancy seem to outweigh the risks.

EDITOR DISCLOSURES AT TIME OF PUBLICATION

Disclosures for Eleanor Bimla Schwarz, MD, MS at time of publication

Grant / Research supportVeterans Health Administration; Department of Health and Human Services; FDA; National Institute of Child Health and Development; American Diabetes Association, W.K. Kellogg Foundation

Editorial boardsContraception

CITATION(S):

Magee LA et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 2015 Jan 29; 372:407. (Δεν είναι ορατοί οι σύνδεσμοι (links). Εγγραφή ή Είσοδος)
- See more at: Δεν είναι ορατοί οι σύνδεσμοι (links). Εγγραφή ή Είσοδος